SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,612 | -82.3% | 155,500 | +14.8% | 0.00% | -100.0% |
| Q2 2023 | $161,923 | +72.9% | 135,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $93,658 | +1.8% | 135,500 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $92,000 | -34.3% | 135,500 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $140,000 | +52.2% | 135,500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $92,000 | -19.3% | 135,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $114,000 | -66.8% | 135,500 | -35.6% | 0.00% | -50.0% |
| Q4 2021 | $343,000 | -44.9% | 210,500 | -18.6% | 0.00% | -50.0% |
| Q3 2021 | $623,000 | -13.7% | 258,500 | -5.5% | 0.00% | -33.3% |
| Q2 2021 | $722,000 | -40.3% | 273,500 | +12.8% | 0.01% | -45.5% |
| Q1 2021 | $1,210,000 | +460.2% | 242,500 | +77.0% | 0.01% | +450.0% |
| Q4 2020 | $216,000 | +980.0% | 137,000 | +585.0% | 0.00% | – |
| Q2 2020 | $20,000 | +100.0% | 20,000 | 0.0% | 0.00% | – |
| Q1 2020 | $10,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 664,477 | $890,000 | 0.05% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $67,000 | 0.01% |
| MYCIO WEALTH PARTNERS, LLC | 30,500 | $41,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $3,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $16,000 | 0.00% |
| Renaissance Technologies | 1,118,623 | $1,499,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 308,794 | $412,000 | 0.00% |
| BlackRock Inc. | 404,056 | $541,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 13,544 | $18,000 | 0.00% |
| JPMORGAN CHASE & CO | 16 | $0 | 0.00% |